PIN31 COST PER CYTOMEGALOVIRUS-ASSOCIATED DEATH AVERTED OF GANCICLOVIR AND VALGANCICLOVIR USE FOR PRE-EMPTIVE AND TREATMENT STRATEGIES IN ALLOGENEIC POSTTRANSPLANT RECIPIENTS
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1275
https://www.valueinhealthjournal.com/article/S1098-3015(19)33653-8/fulltext
Title :
PIN31 COST PER CYTOMEGALOVIRUS-ASSOCIATED DEATH AVERTED OF GANCICLOVIR AND VALGANCICLOVIR USE FOR PRE-EMPTIVE AND TREATMENT STRATEGIES IN ALLOGENEIC POSTTRANSPLANT RECIPIENTS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)33653-8&doi=10.1016/j.jval.2019.09.1275
First page :
Section Title :
Open access? :
No
Section Order :
11115